Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy

NCT00582530 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00582530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00582530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
December 28, 2004
Completion date
June 21, 2022
Enrollment
513 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer